128 related articles for article (PubMed ID: 37820837)
1. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations.
Christensen J; Prosper AE; Wu CC; Chung J; Lee E; Elicker B; Hunsaker AR; Petranovic M; Sandler KL; Stiles B; Mazzone P; Yankelevitz D; Aberle D; Chiles C; Kazerooni E
J Am Coll Radiol; 2024 Mar; 21(3):473-488. PubMed ID: 37820837
[TBL] [Abstract][Full Text] [Related]
2. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations.
Christensen J; Prosper AE; Wu CC; Chung J; Lee E; Elicker B; Hunsaker AR; Petranovic M; Sandler KL; Stiles B; Mazzone P; Yankelevitz D; Aberle D; Chiles C; Kazerooni E
Chest; 2024 Mar; 165(3):738-753. PubMed ID: 38300206
[TBL] [Abstract][Full Text] [Related]
3. Interpreting Lung Cancer Screening CTs: Practical Approach to Lung Cancer Screening and Application of Lung-RADS.
Jhala K; Byrne SC; Hammer MM
Clin Chest Med; 2024 Jun; 45(2):279-293. PubMed ID: 38816088
[TBL] [Abstract][Full Text] [Related]
4. Lung-RADS Version 1.1: Challenges and a Look Ahead, From the
Chelala L; Hossain R; Kazerooni EA; Christensen JD; Dyer DS; White CS
AJR Am J Roentgenol; 2021 Jun; 216(6):1411-1422. PubMed ID: 33470834
[TBL] [Abstract][Full Text] [Related]
5. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C
Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631
[TBL] [Abstract][Full Text] [Related]
6. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
Hammer MM; Hunsaker AR
AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
[No Abstract] [Full Text] [Related]
7. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
Hammer MM; Byrne SC
AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
[No Abstract] [Full Text] [Related]
8. Lung-Reporting and Data System 2.0: Impact of the Updated Approach to Juxtapleural Nodules During Lung Cancer Screening Using the National Lung Cancer Screening Trial Data Set.
Chelala L; Hossain R; Jeudy J; Nader Z; Kastner J; White C
J Thorac Imaging; 2024 Jul; 39(4):241-246. PubMed ID: 37889546
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Lung-RADS Version 1.1 and Lung-RADS Version 2022 in Classifying Airway Nodules Detected at Lung Cancer Screening CT.
DeSimone AK; Byrne SC; Hammer MM
Radiol Cardiothorac Imaging; 2024 Feb; 6(1):e230149. PubMed ID: 38300115
[TBL] [Abstract][Full Text] [Related]
10. The Lung Reporting and Data System (LU-RADS): a proposal for computed tomography screening.
Manos D; Seely JM; Taylor J; Borgaonkar J; Roberts HC; Mayo JR
Can Assoc Radiol J; 2014 May; 65(2):121-34. PubMed ID: 24758919
[TBL] [Abstract][Full Text] [Related]
11. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
[TBL] [Abstract][Full Text] [Related]
12. A Decision Analysis of Follow-up and Treatment Algorithms for Nonsolid Pulmonary Nodules.
Hammer MM; Palazzo LL; Eckel AL; Barbosa EM; Kong CY
Radiology; 2019 Feb; 290(2):506-513. PubMed ID: 30457486
[TBL] [Abstract][Full Text] [Related]
13. Performance of ACR Lung-RADS in a clinical CT lung screening program.
McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Treatment Thresholds for Subsolid Pulmonary Nodules in CT Lung Cancer Screening.
Hammer MM; Eckel AL; Palazzo LL; Kong CY
Radiology; 2021 Sep; 300(3):586-593. PubMed ID: 34128723
[TBL] [Abstract][Full Text] [Related]
15. Interobserver variability in Lung CT Screening Reporting and Data System categorisation in subsolid nodule-enriched lung cancer screening CTs.
Yoon SH; Kim YJ; Doh K; Kim J; Lee KH; Lee KW; Kim J
Eur Radiol; 2021 Sep; 31(9):7184-7191. PubMed ID: 33733688
[TBL] [Abstract][Full Text] [Related]
16. Improved interobserver agreement on nodule type and Lung-RADS classification of subsolid nodules using computer-aided solid component measurement.
Shu J; Wen D; Xu Z; Meng X; Zhang Z; Lin S; Zheng M
Eur J Radiol; 2022 Jul; 152():110339. PubMed ID: 35537358
[TBL] [Abstract][Full Text] [Related]
17. Malignant Nodules Detected on Lung Cancer Screening CT: Yield of Short-Term Follow-Up CT in Showing Nodule Growth.
Byrne SC; Hammer MM
AJR Am J Roentgenol; 2022 Nov; 219(5):735-741. PubMed ID: 35674352
[No Abstract] [Full Text] [Related]
18. Efficacy of Ultrashort Echo Time Pulmonary MRI for Lung Nodule Detection and Lung-RADS Classification.
Ohno Y; Takenaka D; Yoshikawa T; Yui M; Koyama H; Yamamoto K; Hamabuchi N; Shigemura C; Watanabe A; Ueda T; Ikeda H; Hattori H; Murayama K; Toyama H
Radiology; 2022 Mar; 302(3):697-706. PubMed ID: 34846203
[TBL] [Abstract][Full Text] [Related]
19. Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.
van Riel SJ; Ciompi F; Jacobs C; Winkler Wille MM; Scholten ET; Naqibullah M; Lam S; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2017 Oct; 27(10):4019-4029. PubMed ID: 28293773
[TBL] [Abstract][Full Text] [Related]
20. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
